These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 15808768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon.
    Aharinejad S, Andrukhova O, Lucas T, Zuckermann A, Wieselthaler G, Wolner E, Grimm M.
    Ann Thorac Surg; 2008 Jul; 86(1):109-14; discussion 114. PubMed ID: 18573408
    [Abstract] [Full Text] [Related]

  • 3. Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
    Lehmann MH, Kühnert H, Müller S, Sigusch HH.
    Cytokine; 1998 Oct; 10(10):739-46. PubMed ID: 9811526
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.
    Goldin-Lang P, Tran QV, Fichtner I, Eisenreich A, Antoniak S, Schulze K, Coupland SE, Poller W, Schultheiss HP, Rauch U.
    Oncol Rep; 2008 Jul; 20(1):123-8. PubMed ID: 18575726
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 9. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
    Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B, Cerra MC, Bellocci F, Crea F, Maseri A.
    Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of monocyte chemoattractant protein-1 in idiopathic dilated cardiomyopathy.
    Kobayashi M, Nakamura K, Kusano KF, Nakamura Y, Ohta-Ogo K, Nagase S, Sakuragi S, Ohe T.
    Int J Cardiol; 2008 Jun 06; 126(3):427-9. PubMed ID: 17467829
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy.
    Vanderheyden M, Paulus WJ, Voss M, Knuefermann P, Sivasubramanian N, Mann D, Baumgarten G.
    Heart; 2005 Jul 06; 91(7):926-31. PubMed ID: 15958363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
    Vejlstrup NG, Bouloumie A, Boesgaard S, Andersen CB, Nielsen-Kudsk JE, Mortensen SA, Kent JD, Harrison DG, Busse R, Aldershvile J.
    J Mol Cell Cardiol; 1998 Jun 06; 30(6):1215-23. PubMed ID: 9689595
    [Abstract] [Full Text] [Related]

  • 17. Suppressed expression of GTP cyclohydrolase I mRNA and accelerated expression of inducible nitric oxide synthase mRNA in endomyocardial biopsy specimens from patients with dilated cardiomyopathy.
    Ohtsuki M, Nomura T, Morimoto S, Hiramitsu S, Uemura A, Kato S, Kato Y, Shiraishi H, Shimokubo J, Yamamoto N, Hishida H.
    Clin Chim Acta; 2005 Mar 06; 353(1-2):103-7. PubMed ID: 15698596
    [Abstract] [Full Text] [Related]

  • 18. Molecular chaperone, HSP60, and cytochrome P450 2E1 co-expression in dilated cardiomyopathy.
    Sidorik L, Kyyamova R, Bobyk V, Kapustian L, Rozhko O, Vigontina O, Ryabenko D, Danko I, Maksymchuk O, Kovalenko VN, Filonenko VV, Chaschin NA.
    Cell Biol Int; 2005 Jan 06; 29(1):51-5. PubMed ID: 15763499
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhong M, Zhang Y, Miao Y, Li L, Gong HP, Ma X, Sun H, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 24; 86(4):232-6. PubMed ID: 16677501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.